Answers are grounded in this paper and cite their sources.
Key Points Distinct sphingolipid metabolism of AML with MDS-related changes defines unique sensitivity to nanoliposomal C6-ceramide. Vinblastine alters sphingolipid metabolism to enhance the sensitivity of AML to nanoliposomal C6-ceramide.
No takes yet. Share an insight, caveat, or question.
Barth et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: